Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > The big ASK wall is a faked one
View:
Post by ScienceFirst on Mar 29, 2022 9:08pm

The big ASK wall is a faked one

Behavior never lies.   I concur with 99932Apophis that this wall on the ASK side is a faked one.  

For many reasons:

1) We've seen this pattern so many times on the TMX-V for stocks that don't trade with much volume while offering imminent nice upside.

2) Nothing will leak at TLT.  It will be what it will be.  So trying to induce us to believe that we have to leave the boat asap simply doesn't make sense.  Clinical data also never leaks.  Strict rules are in place, for those familiar with the process.  

3) Why one investor, for an important value (initial order was 306,000 shares (so 137,000$)), when we're so close to the goal line, would suddenly want to exit, when the risk/reward is so compelling (low downside risk (88M$CAN to lets see 40M$CAN) versus infinite upside (88M$CAN to 5G$US (36-70x upside potential )), especially since we've been told that:

1) "7/10 patients (70.0%), who achieved a CR at 90 days continue to demonstrate CR at 180 days" and that we could aim at "Hence, the potential for CR is up to 75.8% (**)"  

** Assumes both PR and Pending data are clinically determined to be CR at a later assessment date.


2) In the total population of 18 patients (@ 90 days), who received the optimized treatment

44.4% achieved CR >> 11.1% achieved PR >> 38.9% are Pending >> 5.6% achieved NR

"Hence, the potential for CR is up to 94.4% (***)"

*** Assumes both PR and Pending data are clinically determined to be CR at a later assessment date



0,445 $ 32500 4 0,45 $ 294500 1
0,44 $ 5000 1 0,46 $ 500 1
0,435 $ 20000 1 0,465 $ 5000 1
0,43 $ 15500 2 0,47 $ 254000 6
0,42 $ 20000 1 0,475 $ 25000 3
0,41 $ 10000 3 0,48 $ 37500 4
0,40 $ 49500 1 0,485 $ 2000 1
0,38 $ 10000 1 0,49 $ 26000 3
0,37 $ 15000 2 0,495 $ 26000 3
0,36 $ 8000 1 0,50 $ 15500 3


TLT is trading at very low volume since Feb. 29:

Volume
195143
18000
22920
44155
112056
209449
198569
219777
21294
17350
103600
56900
68100
61000
48500
331579
272558
148675
122833
161195
116721
Comment by AmirKingKhan22 on Mar 29, 2022 10:46pm
2) Clinical data does leak. That has happened for a number of stocks. I can even think of a few instances in TLT's case where a large price change predated news. Although that hasn't happened recently,  3) portfolio rebalancing could be occurring with seller. Impossible to rationalize without seeing their portfolio. Perhaps they want to lower their exposure to binary events. Upside ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250